Botox Cosmetic (onabotulinumtoxinA) receives FDA approval for moderate to severe vertical bands connecting the jaw and neck (platysma bands)

AbbVie

18 October 2024 - The only product of its kind approved for use in four aesthetic indications: temporary improvement in the appearance of moderate to severe forehead lines, frown lines, crow's feet lines, and now platysma bands in adults.

Today, Allergan Aesthetics, an AbbVie company, announced the US FDA approval of Botox Cosmetic for temporary improvement in the appearance of moderate to severe vertical bands connecting the jaw and neck (platysma bands) in adults.

Read AbbVie press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , US